Posted On: 05/13/2016 10:25:17 AM
Post# of 144798
22nd Century Launches Major New Initiative to Produce Medically-Important Marijuana Cannabinoids
22nd Century is only U.S. firm able to operate freely in the cannabinoid biosynthetic pathway; Company intends to produce cost-effective commercial quantities of cannabinoids
http://www.businesswire.com/news/home/2016051...-Important
GWPH, ZYNE, CARA, INSY, ARNA, CANV.
HEMP, CANV, MJNA, VAPE, VPCO, CBIS, TRTC, GRNH, ATTBF, GLUC, ZYNE, CANN, NGBL
22nd Century is only U.S. firm able to operate freely in the cannabinoid biosynthetic pathway; Company intends to produce cost-effective commercial quantities of cannabinoids
http://www.businesswire.com/news/home/2016051...-Important
GWPH, ZYNE, CARA, INSY, ARNA, CANV.
HEMP, CANV, MJNA, VAPE, VPCO, CBIS, TRTC, GRNH, ATTBF, GLUC, ZYNE, CANN, NGBL
(0)
(0)Scroll down for more posts ▼
